Table 1.
PaCO2, mmHg |
PaO2, mmHg |
MAP, mmHg |
|||||||
---|---|---|---|---|---|---|---|---|---|
Treatment groups | Baseline | Hypoxia | 60 min Posthypoxia | Baseline | Hypoxia | 60 min Posthypoxia | Baseline | Hypoxia | 60 min Posthypoxia |
Pre-AIH | |||||||||
Vehicle | 42.2 ± 0.4 | 41.6 ± 0.6 | 41.9 ± 0.4 | 242 ± 22 | 37 ± 2‡* | 250 ± 10 | 120 ± 7 | 92 ± 11* | 102 ± 8 |
Vehicle control | 45.8 ± 0.8† | 45.7 ± 1.3† | 45.7 ± 1.0† | 290 ± 11† | 287 ± 9 | 276 ± 6 | 109 ± 9 | 109 ± 11 | 109 ± 12 |
siBDNF | 46.1 ± 0.7† | 46.3 ± 1.3† | 45.8 ± 0.9† | 285 ± 5 | 39 ± 3‡* | 277 ± 6 | 81 ± 11 | 60 ± 6 | 77 ± 9 |
siTrkB | 46.9 ± 0.5 | 43.6 ± 1.4* | 47.4 ± 0.4† | 292 ± 7 | 38 ± 1‡* | 283 ± 4 | 85 ± 11 | 70 ± 8 | 81 ± 9 |
U0126 | 46.6 ± 0.9† | 46.3 ± 0.9† | 47.0 ± 1.2† | 300 ± 10† | 42 ± 2‡* | 289 ± 15 | 111 ± 5 | 84 ± 10* | 106 ± 5 |
PI-828 | 47.7 ± 1.4† | 46.5 ± 1.4† | 48.5 ± 1.2† | 290 ± 15† | 39 ± 1‡* | 265 ± 21 | 106 ± 6 | 88 ± 7 | 95 ± 4 |
Baseline | Hypoxia | 60 min | Baseline | Hypoxia | 60 min | Baseline | Hypoxia | 60 min | |
---|---|---|---|---|---|---|---|---|---|
Post-AIH | |||||||||
Vehicle | 46.9 ± 2.0 | 49.0 ± 3.0 | 46.7 ± 2.3 | 266 ± 18 | 36 ± 2* | 279 ± 12 | 109 ± 5 | 65 ± 13* | 90 ± 6 |
U0126 | 48.2 ± 1.1 | 47.0 ± 1.7 | 48.3 ± 1.4 | 265 ± 13 | 68 ± 2* | 255 ± 7 | 118 ± 7 | 90 ± 7 | 84 ± 9 |
Vehicle control | 47.5 ± 1.8 | 46.6 ± 1.6 | 46.3 ± 1.9 | 262 ± 19 | 261 ± 23 | 262 ± 16 | 106 ± 7 | 100 ± 9 | 99 ± 9 |
U0126 control | 47.4 ± 2.0 | 46.3 ± 1.2 | 47.3 ± 1.4 | 296 ± 8 | 295 ± 11 | 294 ± 8 | 112 ± 6 | 102 ± 5 | 85 ± 8 |
Values are means ± SE. PaCO2, arterial Pco2; PaO2, arterial Po2; MAP, mean arterial pressure; AIH, acute intermittent hypoxia; siBDNF, small interfering (si)RNA targeting brain-derived neurotrophic factor; siTrkB, siRNA targeting TrkB.
Significantly different than baseline;
significantly different than vehicle (with AIH);
significantly different than vehicle (without AIH) (P < 0.05).